Ryman Healthcare Limited (RHCGF)
USD 2.61
(0.0%)
USD 2.61
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 650.53 Million | 350.46 Million | 349.2 Million | 316.84 Million | 250.24 Million | 259.8 Million |
| Cost of Revenue | 389.88 Million | 362.82 Million | 347.94 Million | 299.52 Million | 224.01 Million | 222.92 Million |
| Gross Profit | 260.65 Million | -12.36 Million | 1.26 Million | 17.32 Million | 26.23 Million | 36.88 Million |
| Operating Expenses | 9.61 Million | 579.87 Million | 501.93 Million | 427.67 Million | 377.86 Million | - |
| Selling, General and Administrative Expenses | 463.91 Million | - | 305.75 Million | 265.49 Million | 233.54 Million | - |
| Research and Development Expenses | 9.61 Million | 7.34 Million | 3.53 Million | 3.58 Million | 2.14 Million | - |
| Other Expenses | - | 440.23 Million | 750.88 Million | 420.12 Million | 145.66 Million | - |
| Cost and Expenses | 399.49 Million | 362.82 Million | 347.94 Million | 299.52 Million | 224.01 Million | 222.92 Million |
| Operating Income | -26.98 Million | -12.36 Million | 1.26 Million | 17.32 Million | 26.23 Million | 36.88 Million |
| Interest Expense | 50.39 Million | 75.12 Million | 21.25 Million | 13.56 Million | 11.44 Million | 12.92 Million |
| Income Tax Expense | -89.47 Million | -32.31 Million | 20.24 Million | -8.79 Million | -55.46 Million | 2.33 Million |
| Earnings before Tax | -86.62 Million | 129.01 Million | 500.54 Million | 287.49 Million | 101.46 Million | 224.66 Million |
| Net Income | 2.85 Million | 161.32 Million | 480.29 Million | 296.29 Million | 156.93 Million | 222.32 Million |
| Earnings Per Share Basic | 0.00 | 0.31 | 0.91 | 0.56 | 0.30 | 0.42 |
| Earnings Per Share Diluted | 0.00 | 0.31 | 0.91 | 0.56 | 0.30 | 0.42 |
| Weighted Average Shares Outstanding | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 530.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 516.32 Million | 530.45 Million | 530.45 Million | 530.45 Million | 530.45 Million |
| Gross Margin | 0.40 | -0.04 | 0.00 | 0.05 | 0.10 | 0.14 |
| EBIT Margin | -0.08 | 0.05 | 0.07 | 0.13 | 0.17 | 0.20 |
| Profit Margin | 0.00 | 0.46 | 1.38 | 0.94 | 0.63 | 0.86 |
| EBITDA | -54.51 Million | 16.78 Million | 546.54 Million | 323.72 Million | 43.19 Million | 52.65 Million |
| Earnings Before Tax Margin | -0.04 | -0.04 | 0.00 | 0.05 | 0.10 | 0.14 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 388.82 Million | 109.41 Million | 115.62 Million | 189.84 Million | 98.72 Million | 350.46 Million |
| Cost of Revenue | 415.81 Million | 107.36 Million | 113.45 Million | 191.26 Million | 89.87 Million | 362.82 Million |
| Gross Profit | -26.98 Million | 2.04 Million | 2.16 Million | -1.42 Million | 8.84 Million | -12.36 Million |
| Operating Expenses | 720.14 Million | 4.8 Million | 78.25 Million | 40.46 Million | 41.43 Million | 579.87 Million |
| Selling, General and Administrative Expenses | - | - | - | - | - | - |
| Research and Development Expenses | - | 4.8 Million | 5.07 Million | - | - | - |
| Other Expenses | 216.57 Million | - | - | 1.00 | - | 440.23 Million |
| Cost and Expenses | 415.81 Million | 112.17 Million | 191.71 Million | 191.26 Million | 131.31 Million | 362.82 Million |
| Operating Income | -26.98 Million | -2.76 Million | -3.4 Million | -1.42 Million | 812.05 Thousand | -12.36 Million |
| Interest Expense | 50.39 Million | 17.29 Million | - | 13.01 Million | - | 75.12 Million |
| Income Tax Expense | -89.47 Million | 31.83 Million | 33.63 Million | -25.92 Million | 13.27 Million | -32.31 Million |
| Earnings before Tax | -86.62 Million | -86.23 Million | -91.12 Million | 85.98 Million | 44.02 Million | 129.01 Million |
| Net Income | 2.85 Million | -54.39 Million | -57.48 Million | 111.91 Million | 57.29 Million | 161.32 Million |
| Earnings Per Share Basic | - | -0.08 | -0.08 | 0.16 | 0.08 | - |
| Earnings Per Share Diluted | - | -0.08 | -0.08 | 0.16 | 0.08 | - |
| Weighted Average Shares Outstanding | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 516.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 687.64 Million | 516.32 Million |
| Gross Margin | -0.07 | 0.02 | 0.02 | -0.01 | 0.09 | -0.04 |
| EBIT Margin | - | 0.00 | 0.01 | 0.08 | 0.08 | - |
| Profit Margin | 0.01 | -0.50 | -0.50 | 0.59 | 0.58 | 0.46 |
| EBITDA | - | 361.09 Thousand | 1.68 Million | 14.27 Million | 8.27 Million | - |
| Earnings Before Tax Margin | -0.07 | -0.03 | -0.03 | -0.01 | 0.01 | -0.04 |
HS2
SPHDF
RKIGF
BGLP
HITI
WANSF